RxDoctor Payments Data

Paul Kreienberg, MD

Vascular Surgery · Albany, NYNPI 1780674564

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (38.5%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Penumbra, Inc. at 36.0% of the total. Reporting peaked in 2019 at $55,797 and has fallen 92.5% since, to $4,174 in 2025. Among vascular surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$115,379in general payments, 2019–2025

Across 509 payments — averaging $226.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Penumbra, Inc.$42K
  • Bard Peripheral Vascular, Inc.$31K
  • W. L. Gore & Associates, Inc.$24K
  • Medtronic$13K
  • Boston Scientific$2K
  • Endologix LLC$564
  • plus $3K from 16 others
$55,258in research payments, 2019–2025

Across 36 payments — averaging $1534.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Laminate Medical Technologies Inc.$18K
  • Penumbra, Inc.$18K
  • Bard Peripheral Vascular, Inc.$15K
  • C. R. Bard, Inc. & Subsidiaries$5K

What the payments were for

  • Consulting fees$44,41238%
  • Speaking & faculty fees$32,37528%
  • Grants$2000%
  • Travel & lodging$13,96012%
  • Food & beverage$23,89421%
  • Education$5380%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$115,379 in reported general payments places this provider in the 90th percentile of 405 vascular surgery providers in New York.

See all vascular surgery providers in New York

Medicare billing

Part B allowed, 2024
$222,151
Medicare patients
471
Services billed
2,844

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen12$95
ClopidogrelClopidogrel Bisulfate18$78

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Albany

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →